GH.US Guardant Health Inc

Healthcare Health Care Providers & Services USA Stocks
151.70 USD
Close of Nov 13, 2026
74.55 191.05
Market cap
USD 20.5B
P/E
-
P/B
55.67x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is GH.US undervalued?

Graham number

The Graham number of Guardant Health Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Guardant Health Inc fundamental analysis

No fundamental analysis for Guardant Health Inc yet.

Guardant Health Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tumor DNA to detect cancer at the molecular level; and Guardant360 Tissue test, a …

Full company profile